Sweeney & Michel
ABBV icon

Sweeney & Michel’s AbbVie ABBV Stock Holding History

Sweeney & Michel’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.61M Buy
9,987
+57
+0.6% +$14.6K 0.7% 26
2026
Q2 		$2.44M Sell
9,930
-109
-1% -$23.5K 0.64% 26
2026
Q1 		$2.07M Sell
10,039
-121
-1% -$26.8K 0.61% 32
2025
Q4 		$2.24M Buy
10,160
+81
+0.8% +$18.5K 0.66% 29
2025
Q3 		$2.32M Buy
10,079
+43
+0.4% +$8.76K 0.78% 27
2025
Q2 		$1.93M Buy
10,036
+162
+2% +$30.1K 0.69% 29
2025
Q1 		$1.73M Buy
+9,874
New +$1.92M 0.76% 27
2024
Q3 		$1.78M Buy
9,426
+305
+3% +$56.9K 0.7% 28
2024
Q2 		$1.53M Buy
9,121
+57
+0.6% +$9.44K 0.65% 28
2024
Q1 		$1.46M Buy
+9,064
New +$1.56M 0.65% 27
2023
Q3 		$1.33M Buy
9,378
+60
+0.6% +$8.81K 0.7% 27
2023
Q2 		$1.39M Sell
9,318
-533
-5% -$78.2K 0.72% 22
2023
Q1 		$1.33M Buy
+9,851
New +$1.51M 0.71% 24

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Sweeney & Michel's ABBV Position: Q3 2026 in Review

Sweeney & Michel increased its AbbVie (ABBV) stake by 0.57% in Q3 2026, buying an estimated $14.6K and bringing the position to 9,987 shares worth $2.61M. The position accounts for 0.7% of the portfolio, ranked #26.

Sweeney & Michel first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Sweeney & Michel held 9,987 shares of AbbVie worth $2.61M as of Q3 2026.
  • Sweeney & Michel bought 57 AbbVie shares in Q3 2026, an estimated $14.6K.
  • AbbVie made up 0.7% of Sweeney & Michel's portfolio in Q3 2026, its #26 holding.
  • Sweeney & Michel first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
  • 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Sweeney & Michel's 13F filing for Q3 2026, filed 16 Oct 2026.